Download presentation
Presentation is loading. Please wait.
Published byDeborah Thompson Modified over 9 years ago
1
Main Figures and Tables
2
Figure 1 Strategy (shall we make a strategy figure here?? )
3
Figure 2. ab Need to replaced by the final figures highlow samples proteins cancercontrol ZW: we can cut the samples labels
4
Figure 3. Signaling pathway analysis of the differential proteins (pathway will be generated either by IPA or KEGG)
5
Table 1.
6
Figure 4.
7
MELK in Adenocacinoma Figure 5. DAPK2 MELK MELK in Squamouse cell carcinoma
8
Table 2. Correlation analysis
9
Supplementary Figures
10
Supplementary Figure S1 – PCA Analysis proteins ABC control cancer control cancer PCA on samples without any filter PCA on samples with p<0.05 PCA on proteins with p<0.05
11
EGFR Squamouse cell carcinoma Adenocarcinoma P = 0,006231 P = 0,03599 high expression Overall Survival Probability low expression high expression low expression Overall Survival [months] Overall Survival Probability 050100 150 200 Overall Survival [months] 0.0 0.2 0.4 0.6 0.8 1.0 050100 150 200 Overall Survival [months] 0.0 0.2 0.4 0.6 0.8 1.0 Supplementary Figure S2
12
DAPK2 Adenocarcinoma & Squamouse cell carcinoma P = 0,008825 low expression (n=45) high expression (n=275) Overall Survival Probability 050 100 150 200 Overall Survival [months] 0.0 0.2 0.4 0.6 0.8 1.0 Supplementary Figure S3 a.
13
DAPK2 P = 0,0198 P = 0,03282 low expression (n=33) high expression (n=113) Overall Survival Probability low expression (n=12) high expression (n=162) 050100 150 200 Overall Survival [months] 0.0 0.2 0.4 0.6 0.8 1.0 050100 150 200 Overall Survival [months] 0.0 0.2 0.4 0.6 0.8 1.0 Squamouse cell carcinoma Adenocarcinoma b.c.
14
MELK Adenocarcinoma & Squamouse cell carcinoma P = 0,043 low expression (n=68) high expression (n=291) Overall Survival Probability 050100 150 200 Overall Survival [months] 0.0 0.2 0.4 0.6 0.8 1.0 Supplementary Figure S4 a.
15
MELK low expression (n=40) high expression (n=139) P = 0,017 Overall Survival Probability P = 0,69 low expression (n=28) high expression (n=153) Overall Survival [months] 0.0 0.2 0.4 0.6 0.8 1.0 050100 150 200 Overall Survival [months] 0.0 0.2 0.4 0.6 0.8 1.0 050100 150 200 Overall Survival [months] 0.0 0.2 0.4 0.6 0.8 1.0 Squamouse cell carcinoma Adenocarcinoma b.c.
16
DDR1 P = 0,0485 moderate expression (n=100) high expression (n=54) Overall Survival Probability Overall Survival [months] P = 0,7228 low expression (n=29) high expression (n=20) low expression (n=157) Overall Survival [months] 050100 150 200 Overall Survival [months] 0.0 0.2 0.4 0.6 0.8 1.0 050100 150 200 Overall Survival [months] 0.0 0.2 0.4 0.6 0.8 1.0 Squamouse cell carcinoma Adenocarcinoma b.c.
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.